LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 54.27 | 17.25 | 1324 | 4884 | 0.2711 | 0.7039 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 54.27 | 17.25 | 1366 | 4884 | 0.2797 | 0.7104 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 56.24 | 17.25 | 1234 | 4929 | 0.2504 | 0.6878 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 56.24 | 17.25 | 1284 | 4929 | 0.2605 | 0.6960 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 56.24 | 17.25 | 1331 | 4929 | 0.2700 | 0.7035 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 56.24 | 17.25 | 1374 | 4929 | 0.2788 | 0.7101 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.21 | 17.25 | 1260 | 4942 | 0.2549 | 0.6917 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.21 | 17.25 | 1307 | 4942 | 0.2644 | 0.6993 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.21 | 17.25 | 1319 | 4942 | 0.2669 | 0.7012 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 58.21 | 17.25 | 1376 | 4942 | 0.2784 | 0.7100 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 60.18 | 17.25 | 1252 | 5031 | 0.2488 | 0.6875 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 60.18 | 17.25 | 1293 | 5031 | 0.2570 | 0.6942 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 60.18 | 17.25 | 1330 | 5031 | 0.2643 | 0.7000 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 60.18 | 17.25 | 1383 | 5031 | 0.2749 | 0.7082 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 63.15 | 17.25 | 1266 | 5061 | 0.2501 | 0.6889 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 63.15 | 17.25 | 1296 | 5061 | 0.2561 | 0.6938 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 63.15 | 17.25 | 1359 | 5061 | 0.2685 | 0.7036 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 63.15 | 17.25 | 1388 | 5061 | 0.2743 | 0.7080 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 65.12 | 17.25 | 1267 | 5095 | 0.2487 | 0.6880 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 65.12 | 17.25 | 1288 | 5095 | 0.2528 | 0.6914 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 65.12 | 17.25 | 1357 | 5095 | 0.2663 | 0.7022 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 65.12 | 17.25 | 1379 | 5095 | 0.2707 | 0.7056 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 67.09 | 17.25 | 1290 | 5221 | 0.2471 | 0.6879 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 67.09 | 17.25 | 1315 | 5221 | 0.2519 | 0.6919 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 67.09 | 17.25 | 1354 | 5221 | 0.2593 | 0.6979 | MN20160310_N02 | I10 |